Flex-Mend
Flex-Mend, licence 80042925: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Enzyme Science
- NPN or DIN-HM
- 80042925
- Status
- Active licence
- Licence date
- 18 June 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Papaïne Source : Papain | 27.0 mg | Not calculated |
| Papaïne Source : Carica papaya, fruit | 27.0 mg | Not calculated |
| Papaïne Source : Papain | 1750000.0 FCC PU | Not calculated |
| Papaïne Source : Carica papaya, fruit | 1750000.0 FCC PU | Not calculated |
| Peroxyde d'hydrogène: oxydo-réductase de peroxyde d'hydrogène Source : Aspergillus niger - En entier | 36.0 mg | Not calculated |
| Peroxyde d'hydrogène: oxydo-réductase de peroxyde d'hydrogène Source : Aspergillus niger - En entier | 50.0 Unité "Baker" du FCC | Not calculated |
| 3-(O-6-désoxy-alpha-l-mannopyranosyl-(1-6)-bêta-d-glucopyranosyloxy)-2-(3,4-dihydroxyphényl)-5,7-dihydroxy-4H-chromen-4-one Source : Rutine | 30.0 mg | Not calculated |
| 3-(O-6-désoxy-alpha-l-mannopyranosyl-(1-6)-bêta-d-glucopyranosyloxy)-2-(3,4-dihydroxyphényl)-5,7-dihydroxy-4H-chromen-4-one Source : Styphnolobium japonicum - Bourgeon floral | 30.0 mg | Not calculated |
| Protéase bactérien Source : Bacillus subtilis - cellule entière | 5.5 mg | Not calculated |
| Protéase bactérien Source : Bacillus subtilis - cellule entière | 1677.5 FCC PC | Not calculated |
Non-medicinal ingredients
Eau purifiée, Triglycérides à chaîne moyenne, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Bromelain is used in Herbal Medicine to help relieve swelling (anti-inflammatory). Digestive enzymes. Rutin is an antioxidant. Protease is a digestive aid. Protease helps digest proteins. Serratiopeptidase helps to reduce pain, quantity of secretion, inability to perceive smell, and stuffy nose from ear, nose and throat infections. Serratiopeptidase is a mucolytic enzyme. Serratiopeptidase helps reduce postoperative cheek swelling and/or pain after dental surgery.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
If pregnant or breastfeeding, do not use.
Source
Official Health Canada record, licence 80042925
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.